American Commercial Lines (ACLI) Announces $100M Order
American Commercial Lines Inc. (NASDAQ: ACLI) entered into a six year, approximately $100 million, multi-vessel contract with a major customer, to build both liquid and dry cargo barges. Construction will begin in 2008.
American Commercial Lines Inc. (NASDAQ: ACLI) entered into a six year, approximately $100 million, multi-vessel contract with a major customer, to build both liquid and dry cargo barges. Construction will begin in 2008.... (continued)
Amphenol Corporation (NYSE: APH) reported that fourth quarter 2007 diluted earnings per share increased 28% to $.55 compared to $.43 per share for the comparable 2006 period versus Q4 '07 consensus estimates of $0.52 per share. Sales for the fourth quarter 2007 increased 18% to $777.3 million compared to $659.4 million for the 2006 period.
Affiliated Computer Services (NYSE: ACS) today announced the Tennessee Bureau of TennCare's intent to award a new contract for the TennCare Management Information... (continued)
Visteon Corporation (NYSE: VC) are expected to make a presentation on January 17, 2008 to investors and security analysts at the Automotive Analysts of New York... (continued)
Force Protection, Inc. (NASDAQ: FRPT) received a $74,130,482 million contract for integrated logistics support (ILS) on the CompanyâÂÂs Cougar MRAP... (continued)
APP Pharmaceuticals, Inc. (NASDAQ: APPX) received approval from the FDA of its Abbreviated New Drug Application for Polymyxin B Sulfate for Injection, USP, 500,000 units/vial, the equivalent of Bedford Laboratories Polymyxin B Sulfate. APP expects to commence marketing the product in the first quarter of 2008. APPâÂÂs polymyxin B is AP-rated, preservative... (continued)
Stereotaxis (NASDAQ: STXS) announced today that the Company has been advised that the U.S. Food and Drug Administration (FDA) has approved its partnered magnetic irrigated catheter for use in mapping and ablation in the United States.
"The long-awaited FDA approval of our partnered irrigated catheter is a very significant milestone for Stereotaxis,"... (continued)
Genzyme Corp. (NASDAQ: GENZ) entered into a license agreement with Moffitt Cancer Center to obtain exclusive worldwide diagnostic testing rights to the discovery... (continued)
ZymoGenetics, Inc. (NASDAQ: ZGEN) said its partner Merck Serono has received agreement from the FDA regarding a Special Protocol Assessment for a Phase 2/3... (continued)
Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) announced the initiation of the phase 2 clinical program for PRO 140, an investigational drug for the treatment... (continued)
A senior Lebanese security official says a bombing in Beirut is believed to have targeted a U.S. Embassy vehicle, and that there are casualties - CNBS... (continued)
Gap Inc. (NYSE: GPS) comparable store sales for March 2007 increased 6 percent. Net sale rose 16% to $1.56 billion.
The company said. "Our comparable store sales improvement in March was driven primarily by customers shopping the week before Easter, the timing of which shifted from April in 2006 to March 2007. While our performance also benefited... (continued)
